"Expected to happen": perspectives on post-release overdose from recently incarcerated people with opioid use disorder.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101153624 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7517 (Electronic) Linking ISSN: 14777517 NLM ISO Abbreviation: Harm Reduct J Subsets: MEDLINE
    • Publication Information:
      Original Publication: [London] : BioMed Central, c2004-
    • Subject Terms:
    • Abstract:
      Background: Opioid-related overdose is the leading cause of death for people recently released from incarceration, however treatment with medications for opioid use disorder (MOUD) during incarceration can reduce the mortality risk. This study seeks to qualitatively analyze perceptions of post-release overdose risk from the perspectives of people who received MOUD while incarcerated in one of eight Massachusetts jails during 2021-2022 using the Risk Environment Framework to guide analyses.
      Methods: N = 38 participants with lived experience of MOUD treatment during incarceration who are now living in the community were interviewed on factors that may contribute to or protect against post-release overdose risk. Themes were identified inductively and deductively using the Risk Environment Framework and its domains, which organizes themes along physical, social, economic, and policy environments on both the micro- and macro- scales.
      Results: The physical risk environment included loss of opioid tolerance during incarceration, polysubstance use, and the toxicity of the regional drug supply as key producers of increased risk for post-release overdose. Social drivers of risk included peer group risk norms-including peer-driven harm reduction practices and interpersonal relationships between drug sellers and buyers-as well as macro-level social determinants of health such as housing insecurity and availability of mental health services. Economic drivers of post-release overdose risk included lack of income generation during incarceration and employment challenges. Participants discussed several aspects of policy that contribute to post-release overdose risk, including availability of harm reduction supplies, public health services, and broader policy around MOUD.
      Conclusions: The perspectives of people with lived experience are vital to understanding the disproportionate risks of overdose for those recently released from incarceration. Our results highlight the intersectional factors that produce and reproduce the post-release overdose risk environment, providing support for interventions across each domain of the Risk Environment Framework. By capturing perspectives from people with lived experience of OUD and incarceration during this critical period of risk, we can better identify interventions that target and mitigate overdose-related harm in this population.
      (© 2024. The Author(s).)
    • References:
      PLoS Med. 2019 Dec 31;16(12):e1003002. (PMID: 31891578)
      JAMA Psychiatry. 2022 Apr 1;79(4):379-381. (PMID: 35234815)
      Drug Alcohol Depend. 2018 Apr 1;185:189-191. (PMID: 29459328)
      Int J Drug Policy. 2020 Jun;80:102769. (PMID: 32446183)
      BMJ. 2017 Apr 26;357:j1550. (PMID: 28446428)
      Anesth Analg. 2017 Nov;125(5):1741-1748. (PMID: 29049118)
      Addiction. 2022 Mar;117(3):532-544. (PMID: 34729849)
      PLOS Glob Public Health. 2023 Mar 22;3(3):e0000769. (PMID: 36962959)
      Int J Prison Health. 2017 Mar 13;13(1):25-31. (PMID: 28299971)
      J Urban Health. 2022 Aug;99(4):701-716. (PMID: 35672547)
      J Rural Health. 2023 Jan;39(1):197-211. (PMID: 35301749)
      Addiction. 2021 Jun;116(6):1460-1471. (PMID: 33047844)
      Addict Sci Clin Pract. 2023 Mar 21;18(1):16. (PMID: 36944998)
      Addict Sci Clin Pract. 2015 Jan 16;10:2. (PMID: 25592182)
      Int J Drug Policy. 2021 Apr;90:103080. (PMID: 33340947)
      Health Justice. 2023 Feb 4;11(1):4. (PMID: 36737503)
      BMC Public Health. 2023 Sep 27;23(1):1869. (PMID: 37752527)
      Int J Drug Policy. 2009 May;20(3):193-201. (PMID: 19147339)
      Harm Reduct J. 2021 Jul 28;18(1):77. (PMID: 34320983)
      N Engl J Med. 2007 Jan 11;356(2):157-65. (PMID: 17215533)
      Subst Use Misuse. 2019;54(6):998-1006. (PMID: 30767590)
      JAMA Netw Open. 2022 Sep 1;5(9):e2232314. (PMID: 36125815)
      Addict Sci Clin Pract. 2019 Apr 15;14(1):17. (PMID: 30982468)
      Am J Public Health. 2022 Apr;112(S2):S151-S158. (PMID: 35262376)
      Drug Alcohol Depend. 2023 Jun 1;247:109867. (PMID: 37084507)
      Drug Alcohol Depend. 2019 May 1;198:1-6. (PMID: 30856370)
      Lancet Reg Health Am. 2022 Dec 23;18:100419. (PMID: 36844014)
      Adm Policy Ment Health. 2011 Jan;38(1):4-23. (PMID: 21197565)
      Int J Drug Policy. 2020 Nov;85:102588. (PMID: 31753603)
      J Subst Abuse Treat. 2019 Jan;96:18-22. (PMID: 30466543)
      Lancet. 2022 Feb 5;399(10324):555-604. (PMID: 35122753)
      JAMA Netw Open. 2023 Sep 5;6(9):e2334540. (PMID: 37721749)
      Int J Drug Policy. 2020 Nov;85:102727. (PMID: 32513621)
      J Subst Abuse Treat. 2021 Sep;128:108275. (PMID: 33483222)
      J Urban Health. 2006 Mar;83(2):150-61. (PMID: 16736365)
      J Subst Abuse Treat. 2016 Mar;62:49-54. (PMID: 26747509)
      Ann Intern Med. 2013 Nov 5;159(9):592-600. (PMID: 24189594)
      Int J Drug Policy. 2023 Dec;122:104252. (PMID: 37980776)
      Int J Drug Policy. 2021 Jan;87:102845. (PMID: 33246303)
    • Grant Information:
      F30 DA058525 United States DA NIDA NIH HHS; UG1 DA050067 United States DA NIDA NIH HHS; 5UG1DA050067-04 United States NH NIH HHS; 1F30DA058525-01A1 United States DA NIDA NIH HHS
    • Contributed Indexing:
      Keywords: Incarceration; Jail; MOUD; Opioid use disorder; Overdose; Qualitative; Risk environment framework
    • Accession Number:
      0 (Analgesics, Opioid)
    • Publication Date:
      Date Created: 20240721 Date Completed: 20240721 Latest Revision: 20240825
    • Publication Date:
      20240826
    • Accession Number:
      PMC11265078
    • Accession Number:
      10.1186/s12954-024-01055-1
    • Accession Number:
      39034384